These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 25088507)

  • 1. Effect of oral N-acetyl cysteine supplementation in type 2 diabetic patients on intracellular glutathione content and innate immune responses to Burkholderia pseudomallei.
    Gamage AM; Lee KO; Gan YH
    Microbes Infect; 2014 Aug; 16(8):661-71. PubMed ID: 25088507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria.
    Tan KS; Lee KO; Low KC; Gamage AM; Liu Y; Tan GY; Koh HQ; Alonso S; Gan YH
    J Clin Invest; 2012 Jun; 122(6):2289-300. PubMed ID: 22546856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glibenclamide impairs responses of neutrophils against Burkholderia pseudomallei by reduction of intracellular glutathione.
    Kewcharoenwong C; Rinchai D; Nithichanon A; Bancroft GJ; Ato M; Lertmemongkolchai G
    Sci Rep; 2016 Oct; 6():34794. PubMed ID: 27713554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory role of GSK3β in the activation of NF-κB and modulation of cytokine levels in Burkholderia pseudomallei-infected PBMC isolated from streptozotocin-induced diabetic animals.
    Maniam P; Nurul Aiezzah Z; Mohamed R; Embi N; Hasidah MS
    Trop Biomed; 2015 Mar; 32(1):36-48. PubMed ID: 25801253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced interleukin-17 expression of Burkholderia pseudomallei-infected peripheral blood mononuclear cells of diabetic patients.
    Pongcharoen S; Ritvirool PN; Sanguansermsri D; Chanchan P; Jienmongkol P; Butkhamchot P; Warnnissorn P; Banchuin N; Sirisinha S
    Asian Pac J Allergy Immunol; 2008 Mar; 26(1):63-9. PubMed ID: 18595531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkholderia pseudomallei induces IL-23 production in primary human monocytes.
    Kulsantiwong P; Pudla M; Boondit J; Wikraiphat C; Dunachie SJ; Chantratita N; Utaisincharoen P
    Med Microbiol Immunol; 2016 Jun; 205(3):255-60. PubMed ID: 26563410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 10 inhibits pro-inflammatory cytokine responses and killing of Burkholderia pseudomallei.
    Kessler B; Rinchai D; Kewcharoenwong C; Nithichanon A; Biggart R; Hawrylowicz CM; Bancroft GJ; Lertmemongkolchai G
    Sci Rep; 2017 Feb; 7():42791. PubMed ID: 28216665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the early host immune response to two widely diverse virulent strains of Burkholderia pseudomallei that cause acute or chronic infections in BALB/c mice.
    Amemiya K; Dankmeyer JL; Fetterer DP; Worsham PL; Welkos SL; Cote CK
    Microb Pathog; 2015 Sep; 86():53-63. PubMed ID: 26162294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of interleukin-1beta expression by peripheral blood mononuclear cells and purified monocytes experimentally infected with Burkholderia pseudomallei and Burkholderia thailandensis.
    Pongcharoen S; Niumsup PR; Butkhamchot P
    Immunol Invest; 2008; 37(7):704-13. PubMed ID: 18821217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes.
    De Mattia G; Bravi MC; Laurenti O; Cassone-Faldetta M; Proietti A; De Luca O; Armiento A; Ferri C
    Diabetologia; 1998 Nov; 41(11):1392-6. PubMed ID: 9833950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered macrophage function is associated with severe Burkholderia pseudomallei infection in a murine model of type 2 diabetes.
    Hodgson KA; Morris JL; Feterl ML; Govan BL; Ketheesan N
    Microbes Infect; 2011 Dec; 13(14-15):1177-84. PubMed ID: 21835260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of a cell-mediated immune response in melioidosis.
    Ketheesan N; Barnes JL; Ulett GC; VanGessel HJ; Norton RE; Hirst RG; LaBrooy JT
    J Infect Dis; 2002 Jul; 186(2):286-9. PubMed ID: 12134268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The innate interferon gamma response of BALB/c and C57BL/6 mice to in vitro Burkholderia pseudomallei infection.
    Koo GC; Gan YH
    BMC Immunol; 2006 Aug; 7():19. PubMed ID: 16919160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supplementation of N-acetylcysteine fails to increase glutathione in lymphocytes and plasma of patients with AIDS.
    Witschi A; Junker E; Schranz C; Speck RF; Lauterburg BH
    AIDS Res Hum Retroviruses; 1995 Jan; 11(1):141-3. PubMed ID: 7734187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed death ligand 1 on Burkholderia pseudomallei-infected human polymorphonuclear neutrophils impairs T cell functions.
    Buddhisa S; Rinchai D; Ato M; Bancroft GJ; Lertmemongkolchai G
    J Immunol; 2015 May; 194(9):4413-21. PubMed ID: 25801435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects.
    Chanchamroen S; Kewcharoenwong C; Susaengrat W; Ato M; Lertmemongkolchai G
    Infect Immun; 2009 Jan; 77(1):456-63. PubMed ID: 18955471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental Persistent Infection of BALB/c Mice with Small-Colony Variants of Burkholderia pseudomallei Leads to Concurrent Upregulation of PD-1 on T Cells and Skewed Th1 and Th17 Responses.
    See JX; Samudi C; Saeidi A; Menon N; Choh LC; Vadivelu J; Shankar EM
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004503. PubMed ID: 26974441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive immunity in melioidosis: a possible role for T cells in determining outcome of infection with Burkholderia pseudomallei.
    Barnes JL; Warner J; Melrose W; Durrheim D; Speare R; Reeder JC; Ketheesan N
    Clin Immunol; 2004 Oct; 113(1):22-8. PubMed ID: 15380526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of NADPH oxidase is essential, but not sufficient, in controlling intracellular multiplication of Burkholderia pseudomallei in primary human monocytes.
    Wikraiphat C; Pudla M; Baral P; Kitthawee S; Utaisincharoen P
    Pathog Dis; 2014 Jun; 71(1):69-72. PubMed ID: 24376210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of defective early immune responses to Burkholderia pseudomallei infection in a diet-induced murine model of type 2 diabetes.
    Morris JL; Govan BL; Rush CM; Ketheesan N
    Microbes Infect; 2021; 23(4-5):104793. PubMed ID: 33571673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.